|Articles|July 1, 2010
- BioPharm International-07-01-2010
- Volume 23
- Issue 7
BioPharm International, July 2010 Issue (PDF)
Robust Strategies to Optimize Processes
Advertisement
Articles in this issue
over 15 years ago
How to Apply Risk Assessment Techniques to Outsourcingover 15 years ago
Capital Market's Woes Weigh Heavily on Biotechover 15 years ago
How Outsourcing Can Accelerate Early CMC Developmentover 15 years ago
Robust Experimental Strategies for Improving Upstream Productivityover 15 years ago
How to Reduce Unnecessary Compliance Costsover 15 years ago
Highly Similarover 15 years ago
Industry Input Needed on Bioassay Standardsover 15 years ago
The Effect of Limiting Phosphate Using the HMS174 Cell Lineover 15 years ago
What the Pharmaceutical Industry Can Learn From Toyota's RecallsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
